Monitor future Form 4 filings for open-market purchases or sales by Caruso, which would provide a clearer signal on insider conviction. No immediate trading catalyst from this filing.
Price Chart
Executive Summary
Andrea Caruso filed a Form 3 initial statement of beneficial ownership upon becoming an officer (CVP & CHRO) of Integra LifeSciences Holdings Corp. The filing discloses 43,590 shares of common stock and six tranches of non-qualified stock options totaling 26,211 shares, with exercise prices ranging from $23.95 to $68.10 and expiration dates from 2028 to 2033. This is a routine insider onboarding filing with no market-moving information.
Key Facts
- Andrea Caruso appointed CVP & CHRO of Integra LifeSciences Holdings Corp
- Form 3 filed 2026-10-13, period of report 2026-10-01
- Beneficial ownership: 43,590 shares of common stock
- Holds 6 non-qualified stock option tranches (total 26,211 shares) with exercise prices $23.95–$68.10, expiring 2028–2033
- Options vest 25% per year over four years from grant dates (2020–2025)
Financial Impact
No financial impact — routine insider initial ownership filing
Risk Factors
- No material risks identified from this routine filing
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0002159797-26-000003 |
| Document: 0002159797-26-000003-index-headers.html | 0002159797-26-000003 |
| Document: 0002159797-26-000003-index.html | 0002159797-26-000003 |
| Document: 0002159797-26-000003.txt | 0002159797-26-000003 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 8-K | $11.84 | awaiting T+5 | — | $12.13 (−2.41%) |
Oct 19, 2026 6d ago | 8-K | $13.33 | awaiting T+5 | — | $12.13 (−9.04%) |
Oct 14, 2026 12d ago | Court Ruling | $13.53 $12.33 | ▼ −8.91% | ▼ −7.89% | $12.13 (−10.38%) |
Oct 13, 2026 12d ago | 3 | $13.18 $11.84 | ▼ −10.13% | ▼ −10.59% | $12.13 (−7.97%) |
Oct 9, 2026 16d ago | 8-K | $13.98 $13.45 | ▲ +3.79% | ▲ +2.30% | $12.13 (+13.27%) |
Oct 6, 2026 20d ago | Press Release | $13.32 | awaiting T+5 | — | $12.13 (−8.97%) |
Oct 2, 2026 24d ago | 8-K | $12.68 $13.44 | ▼ −5.99% | ▼ −4.83% | $12.13 (+4.38%) |
Oct 2, 2026 24d ago | Press Release | $12.68 $13.44 | ▼ −5.99% | ▼ −4.83% | $12.13 (+4.38%) |
Sep 8, 2026 6w ago | 8-K | $16.26 $15.71 | ▼ −3.38% | ▼ −2.72% | $12.13 (−25.43%) |
May 8, 2026 24w ago | 8-K | $13.97 $14.11 | ▲ +1.00% | ▲ +1.09% | $12.13 (−13.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers